Literature DB >> 2990767

Proopiomelanocortin-derived peptides in the immune system.

J E Blalock.   

Abstract

Cells of the immune system have recently been recognized as a source of the proopiomelanocortin (POMC)-derived peptides, ACTH and endorphins, and their receptors. In this review, the nature of the immunoregulatory and hypothalamic signals which elicit the production of these leukocyte-derived hormones is discussed. Further, comparisons are made between the various proteolytic processing patterns of POMC in leukocytes as compared with those observed in the hypothalamus and anterior or intermediate lobes of the pituitary gland. The possible functioning of leukocyte-derived ACTH and endorphins as well as their pituitary counterparts in a complete regulatory loop between the neuroendocrine and immune systems is described.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990767     DOI: 10.1111/j.1365-2265.1985.tb00173.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  10 in total

1.  Immunoreactive opioid peptides in human breast cancer.

Authors:  L Scopsi; E Balslev; N Brünner; H S Poulsen; J Andersen; F Rank; L I Larsson
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

2.  Hormones and behaviour: discussion paper.

Authors:  B T Donovan
Journal:  J R Soc Med       Date:  1987-08       Impact factor: 5.344

3.  Inhibition of stress-induced neuroendocrine and behavioral responses in the rat by prepro-thyrotropin-releasing hormone 178-199.

Authors:  R F McGivern; P Rittenhouse; F Aird; L D Van de Kar; E Redei
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

4.  Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells.

Authors:  P K Peterson; B Sharp; G Gekker; C Brummitt; W F Keane
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

5.  Drug use patterns: implications for the acquired immunodeficiency syndrome.

Authors:  L S Brown; R Evans; D Murphy; B J Primm
Journal:  J Natl Med Assoc       Date:  1986-12       Impact factor: 1.798

6.  Evidence for the production and action of interleukin-10 in pituitary cells.

Authors:  T K Hughes; P Cadet; P L Rady; S K Tyring; R Chin; E M Smith
Journal:  Cell Mol Neurobiol       Date:  1994-02       Impact factor: 5.046

Review 7.  Melanocortin Regulation of Inflammation.

Authors:  Wei Wang; Dong-Yu Guo; Yue-Jun Lin; Ya-Xiong Tao
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-09       Impact factor: 5.555

8.  Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases.

Authors:  Carl Spana; Andrew W Taylor; David G Yee; Marie Makhlina; Wei Yang; John Dodd
Journal:  Front Pharmacol       Date:  2019-01-14       Impact factor: 5.810

Review 9.  Roles of β-Endorphin in Stress, Behavior, Neuroinflammation, and Brain Energy Metabolism.

Authors:  Alexander Pilozzi; Caitlin Carro; Xudong Huang
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

10.  Melanocortin receptors as novel effectors of macrophage responses in inflammation.

Authors:  Hetal B Patel; Trinidad Montero-Melendez; Karin V Greco; Mauro Perretti
Journal:  Front Immunol       Date:  2011-09-13       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.